CN108865969A - Mapk/pkc信号通路激活剂促进人类胆管细胞分化和成熟 - Google Patents
Mapk/pkc信号通路激活剂促进人类胆管细胞分化和成熟 Download PDFInfo
- Publication number
- CN108865969A CN108865969A CN201710329768.7A CN201710329768A CN108865969A CN 108865969 A CN108865969 A CN 108865969A CN 201710329768 A CN201710329768 A CN 201710329768A CN 108865969 A CN108865969 A CN 108865969A
- Authority
- CN
- China
- Prior art keywords
- cell
- bile duct
- mankind
- stones
- mapk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000043136 MAP kinase family Human genes 0.000 title claims abstract description 24
- 108091054455 MAP kinase family Proteins 0.000 title claims abstract description 24
- 239000012190 activator Substances 0.000 title claims abstract description 19
- 210000000013 bile duct Anatomy 0.000 title abstract description 42
- 230000004069 differentiation Effects 0.000 title description 24
- 230000035800 maturation Effects 0.000 title description 4
- 210000004027 cell Anatomy 0.000 claims abstract description 108
- 210000003228 intrahepatic bile duct Anatomy 0.000 claims abstract description 64
- 210000004185 liver Anatomy 0.000 claims abstract description 43
- 238000000034 method Methods 0.000 claims abstract description 40
- 210000000130 stem cell Anatomy 0.000 claims abstract description 30
- 230000006698 induction Effects 0.000 claims abstract description 27
- 210000004039 endoderm cell Anatomy 0.000 claims abstract description 23
- -1 small molecule compound Chemical class 0.000 claims abstract description 20
- WOLVEMPZUIFSII-IHHOKICGSA-N (2e,4e)-n-[(2s,5s)-5-(hydroxymethyl)-1-methyl-3-oxo-2-propan-2-yl-2,4,5,6-tetrahydro-1,4-benzodiazocin-8-yl]-5-[4-(trifluoromethyl)phenyl]penta-2,4-dienamide Chemical compound CN([C@H](C(N[C@H](CO)CC1=C2)=O)C(C)C)C1=CC=C2NC(=O)\C=C\C=C\C1=CC=C(C(F)(F)F)C=C1 WOLVEMPZUIFSII-IHHOKICGSA-N 0.000 claims description 21
- 101100046776 Arabidopsis thaliana TPPB gene Proteins 0.000 claims description 21
- 210000002894 multi-fate stem cell Anatomy 0.000 claims description 12
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 9
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 claims description 8
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims description 8
- 101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 claims description 8
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 6
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 5
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- 238000012549 training Methods 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 6
- 239000001963 growth medium Substances 0.000 description 24
- 108020004414 DNA Proteins 0.000 description 20
- 239000000203 mixture Substances 0.000 description 19
- 108090000623 proteins and genes Proteins 0.000 description 15
- 241000699666 Mus <mouse, genus> Species 0.000 description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 8
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 8
- 230000014509 gene expression Effects 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 7
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000005090 green fluorescent protein Substances 0.000 description 7
- 230000002440 hepatic effect Effects 0.000 description 7
- 108010082117 matrigel Proteins 0.000 description 7
- 108010023082 activin A Proteins 0.000 description 6
- 230000024245 cell differentiation Effects 0.000 description 6
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 6
- 238000000513 principal component analysis Methods 0.000 description 6
- 102000006467 TATA-Box Binding Protein Human genes 0.000 description 5
- 108010044281 TATA-Box Binding Protein Proteins 0.000 description 5
- 229960005070 ascorbic acid Drugs 0.000 description 5
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 238000004043 dyeing Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000010166 immunofluorescence Methods 0.000 description 5
- 210000001778 pluripotent stem cell Anatomy 0.000 description 5
- 101000975502 Homo sapiens Keratin, type II cytoskeletal 7 Proteins 0.000 description 4
- 101000711846 Homo sapiens Transcription factor SOX-9 Proteins 0.000 description 4
- 102100023974 Keratin, type II cytoskeletal 7 Human genes 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 102100034204 Transcription factor SOX-9 Human genes 0.000 description 4
- 210000004738 parenchymal cell Anatomy 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 201000003883 Cystic fibrosis Diseases 0.000 description 3
- 102100022054 Hepatocyte nuclear factor 4-alpha Human genes 0.000 description 3
- 101001045740 Homo sapiens Hepatocyte nuclear factor 4-alpha Proteins 0.000 description 3
- 101000998011 Homo sapiens Keratin, type I cytoskeletal 19 Proteins 0.000 description 3
- 102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 description 3
- 102000009618 Transforming Growth Factors Human genes 0.000 description 3
- 108010009583 Transforming Growth Factors Proteins 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000007877 drug screening Methods 0.000 description 3
- 230000013020 embryo development Effects 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 108010059616 Activins Proteins 0.000 description 2
- 208000017283 Bile Duct disease Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 102100031480 Dual specificity mitogen-activated protein kinase kinase 1 Human genes 0.000 description 2
- 101710146526 Dual specificity mitogen-activated protein kinase kinase 1 Proteins 0.000 description 2
- 102100026818 Inhibin beta E chain Human genes 0.000 description 2
- 229940124647 MEK inhibitor Drugs 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- 238000003559 RNA-seq method Methods 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000000488 activin Substances 0.000 description 2
- 230000011748 cell maturation Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 230000000763 evoking effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 238000010146 3D printing Methods 0.000 description 1
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000004888 Aquaporin 1 Human genes 0.000 description 1
- 108090001004 Aquaporin 1 Proteins 0.000 description 1
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- 108091033409 CRISPR Proteins 0.000 description 1
- AQGNHMOJWBZFQQ-UHFFFAOYSA-N CT 99021 Chemical compound CC1=CNC(C=2C(=NC(NCCNC=3N=CC(=CC=3)C#N)=NC=2)C=2C(=CC(Cl)=CC=2)Cl)=N1 AQGNHMOJWBZFQQ-UHFFFAOYSA-N 0.000 description 1
- 241000766026 Coregonus nasus Species 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 102100028412 Fibroblast growth factor 10 Human genes 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101000653497 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) TATA-box-binding protein F Proteins 0.000 description 1
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 1
- 101000917237 Homo sapiens Fibroblast growth factor 10 Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 102000001756 Notch2 Receptor Human genes 0.000 description 1
- 108010029751 Notch2 Receptor Proteins 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 108010086019 Secretin Proteins 0.000 description 1
- 102100037505 Secretin Human genes 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 102000006747 Transforming Growth Factor alpha Human genes 0.000 description 1
- 101800004564 Transforming growth factor alpha Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 239000002771 cell marker Substances 0.000 description 1
- 230000030570 cellular localization Effects 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 210000003981 ectoderm Anatomy 0.000 description 1
- 210000001900 endoderm Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001842 enterocyte Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003386 epithelial cell of thymus gland Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 210000000630 fibrocyte Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000026273 gall bladder development Effects 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 238000010363 gene targeting Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000030553 intrahepatic bile duct development Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000031142 liver development Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000008672 reprogramming Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 229960002101 secretin Drugs 0.000 description 1
- OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 238000011172 small scale experimental method Methods 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/12—Hepatocyte growth factor [HGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/148—Transforming growth factor alpha [TGF-a]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases [EC 2.]
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/73—Hydrolases (EC 3.)
- C12N2501/734—Proteases (EC 3.4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710329768.7A CN108865969B (zh) | 2017-05-11 | 2017-05-11 | Mapk/pkc信号通路激活剂促进人类胆管细胞分化和成熟 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710329768.7A CN108865969B (zh) | 2017-05-11 | 2017-05-11 | Mapk/pkc信号通路激活剂促进人类胆管细胞分化和成熟 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108865969A true CN108865969A (zh) | 2018-11-23 |
CN108865969B CN108865969B (zh) | 2022-04-01 |
Family
ID=64319606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710329768.7A Active CN108865969B (zh) | 2017-05-11 | 2017-05-11 | Mapk/pkc信号通路激活剂促进人类胆管细胞分化和成熟 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108865969B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111304147A (zh) * | 2018-12-11 | 2020-06-19 | 中国科学院分子细胞科学卓越创新中心 | 利用内胚层干细胞规模化制备功能性胆管细胞的方法及其应用 |
CN111334462A (zh) * | 2018-12-18 | 2020-06-26 | 中国科学院分子细胞科学卓越创新中心 | 抑制egf信号通路促进内胚层干细胞所得肝实质细胞的终末成熟 |
CN111394297A (zh) * | 2018-12-17 | 2020-07-10 | 中国科学院分子细胞科学卓越创新中心 | 内胚层干细胞规模化制备功能性肝母细胞与肝实质细胞的方法及其应用 |
CN113637630A (zh) * | 2020-05-11 | 2021-11-12 | 中国科学院分子细胞科学卓越创新中心 | 一种胰岛样细胞团及其制法和应用 |
WO2022178986A1 (zh) * | 2021-02-26 | 2022-09-01 | 澳门大学 | 一种诱导干细胞分化成中胚层谱系或滋养细胞谱系的方法及药物 |
CN113234664B (zh) * | 2021-05-11 | 2024-05-10 | 澳门大学 | 一种胰腺祖细胞的制备方法及其应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101684454A (zh) * | 2008-09-25 | 2010-03-31 | 中国科学院上海生命科学研究院 | 一种定型内胚层细胞的制备和分离方法 |
CN101962628A (zh) * | 2009-07-24 | 2011-02-02 | 北京大学 | 肝脏内胚层细胞及其制备和纯化方法 |
CN105121632A (zh) * | 2013-02-18 | 2015-12-02 | 大学健康网络 | 由多能干细胞生成肝细胞和胆管细胞的方法 |
WO2017048193A1 (en) * | 2015-09-15 | 2017-03-23 | Agency For Science, Technology And Research (A*Star) | Derivation of liver organoids from human pluripotent stem cells |
-
2017
- 2017-05-11 CN CN201710329768.7A patent/CN108865969B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101684454A (zh) * | 2008-09-25 | 2010-03-31 | 中国科学院上海生命科学研究院 | 一种定型内胚层细胞的制备和分离方法 |
CN101962628A (zh) * | 2009-07-24 | 2011-02-02 | 北京大学 | 肝脏内胚层细胞及其制备和纯化方法 |
CN105121632A (zh) * | 2013-02-18 | 2015-12-02 | 大学健康网络 | 由多能干细胞生成肝细胞和胆管细胞的方法 |
WO2017048193A1 (en) * | 2015-09-15 | 2017-03-23 | Agency For Science, Technology And Research (A*Star) | Derivation of liver organoids from human pluripotent stem cells |
Non-Patent Citations (2)
Title |
---|
FOTIOS SAMPAZIOTIS1 ET AL.: "Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation", 《NAT BIOTECHNOL》 * |
孙博等: "人胚胎干细胞向肝脏样细胞诱导分化中限定性内胚层分化的研究进展", 《国际生殖健康/计划生育杂志》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111304147A (zh) * | 2018-12-11 | 2020-06-19 | 中国科学院分子细胞科学卓越创新中心 | 利用内胚层干细胞规模化制备功能性胆管细胞的方法及其应用 |
CN111394297A (zh) * | 2018-12-17 | 2020-07-10 | 中国科学院分子细胞科学卓越创新中心 | 内胚层干细胞规模化制备功能性肝母细胞与肝实质细胞的方法及其应用 |
CN111334462A (zh) * | 2018-12-18 | 2020-06-26 | 中国科学院分子细胞科学卓越创新中心 | 抑制egf信号通路促进内胚层干细胞所得肝实质细胞的终末成熟 |
CN111334462B (zh) * | 2018-12-18 | 2023-03-21 | 中国科学院分子细胞科学卓越创新中心 | 抑制egf信号通路促进内胚层干细胞所得肝实质细胞的终末成熟 |
CN113637630A (zh) * | 2020-05-11 | 2021-11-12 | 中国科学院分子细胞科学卓越创新中心 | 一种胰岛样细胞团及其制法和应用 |
CN113637630B (zh) * | 2020-05-11 | 2024-03-29 | 中国科学院分子细胞科学卓越创新中心 | 一种胰岛样细胞团及其制法和应用 |
WO2022178986A1 (zh) * | 2021-02-26 | 2022-09-01 | 澳门大学 | 一种诱导干细胞分化成中胚层谱系或滋养细胞谱系的方法及药物 |
CN113234664B (zh) * | 2021-05-11 | 2024-05-10 | 澳门大学 | 一种胰腺祖细胞的制备方法及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN108865969B (zh) | 2022-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108865969A (zh) | Mapk/pkc信号通路激活剂促进人类胆管细胞分化和成熟 | |
Lynch et al. | Submucosal gland myoepithelial cells are reserve stem cells that can regenerate mouse tracheal epithelium | |
JP7023820B2 (ja) | 多分化能細胞および多能性細胞の分化を方向付けることによって発生させる皮質介在ニューロンおよびその他のニューロン細胞 | |
ES2307969T3 (es) | Cultivo celular. | |
CN109996870A (zh) | 从人多能干细胞产生中脑特异性类器官 | |
Tian et al. | Human pluripotent stem cell‐derived lung organoids: Potential applications in development and disease modeling | |
CN108367099A (zh) | 来自多能干细胞的人皮肤类器官的衍生 | |
Hopyan et al. | Budding behaviors: growth of the limb as a model of morphogenesis | |
KR20170110579A (ko) | 신장 오가노이드를 형성시키기 위한 다능성 줄기세포의 분화 | |
JP2021500929A (ja) | 組成物および方法 | |
CN104755607A (zh) | 多能哺乳动物细胞的体外胰腺分化 | |
CN107208056A (zh) | 原始肠内胚层细胞及其制作方法 | |
CN103834613B (zh) | 制备多能心血管前体细胞及维持其心血管分化能力的方法 | |
CN111065732A (zh) | 肿瘤类器官模型 | |
KR102146274B1 (ko) | 장관 오가노이드의 제조 방법 및 이의 용도 | |
Mohlin et al. | Maintaining multipotent trunk neural crest stem cells as self-renewing crestospheres | |
CN101993852B (zh) | 乳腺干细胞的培养基、培养方法及富含乳腺干细胞的混合物 | |
JP7274683B2 (ja) | 多能性幹細胞から樹状分岐した集合管を伴う腎臓構造を作製する方法 | |
Zhang et al. | Highly reproducible and cost-effective one-pot organoid differentiation using a novel platform based on PF-127 triggered spheroid assembly | |
WO2020235319A1 (ja) | 軟骨又は骨の前駆細胞の拡大培養方法 | |
CN113943755A (zh) | 构建原位原发食管癌动物模型的方法 | |
WO2021251418A1 (ja) | 内耳前駆細胞の製造方法、内耳有毛細胞の製造方法、薬剤の評価方法、及び内耳細胞分化誘導用組成物 | |
TW201542817A (zh) | 體外小腸幹細胞培養基及培養方法 | |
CN105073978B (zh) | 利用植物干细胞或植物去分化干细胞的提取物诱导定制亚全能干细胞的方法以及利用该方法的方式制得的亚全能干细胞 | |
CN115786245B (zh) | 人仿生肺脏类器官构建方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 100871 No. 5, the Summer Palace Road, Beijing, Haidian District Patentee after: Peking University Patentee after: Shanghai Institute of nutrition and health, Chinese Academy of Sciences Address before: 100871 No. 5, the Summer Palace Road, Beijing, Haidian District Patentee before: Peking University Patentee before: SHANGHAI INSTITUTES FOR BIOLOGICAL SCIENCES, CHINESE ACADEMY OF SCIENCES |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230720 Address after: 100871 No. 5, the Summer Palace Road, Beijing, Haidian District Patentee after: Peking University Patentee after: Center for excellence and innovation of molecular cell science, Chinese Academy of Sciences Address before: 100871 No. 5, the Summer Palace Road, Beijing, Haidian District Patentee before: Peking University Patentee before: Shanghai Institute of nutrition and health, Chinese Academy of Sciences |